This affords an opportunity to exploit the unique properties of CD37 to generate therapeutics that: (1) maintain the Fc-mediated effector functions of IgG1, (2) deliver toxin into tumor cells through endocytosis, and (3) mediate potent antibody-induced apoptosis. The gene discussed is CD37; the disease is neoplasm.